Filing Details

Accession Number:
0001189724-16-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-31 18:58:01
Reporting Period:
2016-03-31
Filing Date:
2016-03-31
Accepted Time:
2016-03-31 18:58:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
883984 Icu Medical Inc ICUI Surgical & Medical Instruments & Apparatus (3841) 330022692
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189724 Steven Riggs 951 Calle Amanecer
San Clemente CA 92673
Vp Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-31 683 $46.53 2,061 No 4 X Direct
Common Stock Disposition 2016-03-31 683 $105.00 1,378 No 4 S Direct
Common Stock Acquisiton 2016-03-31 1,599 $58.79 2,977 No 4 X Direct
Common Stock Disposition 2016-03-31 1,599 $105.00 1,378 No 4 S Direct
Common Stock Acquisiton 2016-03-31 17,718 $61.76 19,096 No 4 X Direct
Common Stock Disposition 2016-03-31 17,718 $105.00 1,378 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
No 4 X Direct
No 4 S Direct
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2016-03-31 683 $46.53 683 $46.53
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2016-03-31 1,599 $58.79 1,599 $58.79
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2016-03-31 17,718 $61.76 17,718 $61.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-02-01 No 4 X Direct
123,401 2024-02-24 No 4 X Direct
5,906 2023-02-06 No 4 X Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17,2016.
  2. Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
  3. Transaction is the exercise of a derivative security; see Column 2.
  4. Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.